investor_presentation
ALROSA
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Sequana Medical presents innovations in treating diuretic-resistant fluid overload across liver disease, malignant ascites, and heart failure. The company discusses the alfapump® system, currently under clinical investigation in the POSEIDON Study, and DSR® therapy in development. The presentation includes regulatory status, risk factors, and forward-looking statements regarding the company's therapeutic solutions.
conference
21 Pages
investor_presentation
40 Pages
Royal Gold, Inc.
investor_presentation
ALROSA
Teva Pharmaceutical Industries Investor Presentation — March 2021
investor_presentationinvestor_presentation
18 Pages
Teva Pharmaceutical Industries
Natural Grocers NGVC Investor Presentation August 2022
investor_presentationinvestor_presentation
23 Pages
Natural Grocers by Vitamin Cottage, Inc.